|
ADAM17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.826620E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.35899999999623E-05 |
| Normal-vs-Stage2 |
2.148300E-02 |
| Normal-vs-Stage3 |
2.728300E-02 |
| Normal-vs-Stage4 |
5.238100E-02 |
| Stage1-vs-Stage2 |
7.049600E-01 |
| Stage1-vs-Stage3 |
7.919600E-02 |
| Stage1-vs-Stage4 |
1.400440E-01 |
| Stage2-vs-Stage3 |
4.337000E-01 |
| Stage2-vs-Stage4 |
4.996400E-01 |
| Stage3-vs-Stage4 |
9.787000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.032400E-04 |
| Normal-vs-AfricanAmerican |
6.387500E-02 |
| Normal-vs-Asian |
4.902400E-03 |
| Caucasian-vs-AfricanAmerican |
6.940600E-01 |
| Caucasian-vs-Asian |
1.768170E-01 |
| AfricanAmerican-vs-Asian |
2.217800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.764110E-03 |
| Normal-vs-Female |
4.29060000000092E-05 |
| Male-vs-Female |
1.083640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.129830E-01 |
| Normal-vs-Age(41-60Yrs) |
7.64530000000319E-05 |
| Normal-vs-Age(61-80Yrs) |
1.344560E-03 |
| Normal-vs-Age(81-100Yrs) |
9.139200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.031200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.210200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.526220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.711400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.142300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.090000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.51519999999472E-05 |
| Normal-vs-Grade 2 |
2.28729999995902E-06 |
| Normal-vs-Grade 3 |
7.035700E-02 |
| Normal-vs-Grade 4 |
2.117800E-02 |
| Grade 1-vs-Grade 2 |
1.410770E-01 |
| Grade 1-vs-Grade 3 |
1.818760E-03 |
| Grade 1-vs-Grade 4 |
6.220400E-02 |
| Grade 2-vs-Grade 3 |
3.437500E-04 |
| Grade 2-vs-Grade 4 |
2.196000E-01 |
| Grade 3-vs-Grade 4 |
2.714800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.21040000000828E-05 |
| Normal-vs-ccB subtype |
1.459560E-03 |
| ccA subtype-vs-ccB subtype |
4.616200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.214400E-04 |
| Normal-vs-N1 |
1.859620E-01 |
| N0-vs-N1 |
7.753000E-01 |
|
|
